Cytokeratin 19 fragment

You have access
Serum CYFRA 21-1 Level as a Prognostic Marker for Extensive Disease Small Cell Lung Cancer
MAKOTO NAKAO, RYOSUKE KINOSHITA, MAMIKO KURIYAMA, HIROKO KIYOTOSHI, MASAHIRO SUGIHARA, NORIHISA TAKEDA, KAZUHIRO OHTAKARA and HIDEKI MURAMATSU

Anticancer Research February 2024, 44 (2) 845-851; DOI: https://doi.org/10.21873/anticanres.16877
You have access
Predictive and Prognostic Value of CYFRA 21-1 for Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
AKIRA TAKEUCHI, TETSUYA OGURI, KAZUKI SONE, KEIMA ITO, YUKI KITAMURA, YOSHITSUGU INOUE, TAKAMITSU ASANO, SATOSHI FUKUDA, YOSHIHIRO KANEMITSU, OSAMU TAKAKUWA, HIROTSUGU OHKUBO, MASAYA TAKEMURA, KEN MAENO, YUTAKA ITO and AKIO NIIMI

Anticancer Research October 2017, 37 (10) 5771-5776;
You have access
Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-small Cell Lung Cancer Patients
KAZUKI SONE, TETSUYA OGURI, KEIMA ITO, YUKI KITAMURA, YOSHITSUGU INOUE, AKIRA TAKEUCHI, SATOSHI FUKUDA, OSAMU TAKAKUWA, KEN MAENO, TAKAMITSU ASANO, YOSHIHIRO KANEMITSU, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI

Anticancer Research September 2017, 37 (9) 5125-5131;
You have access
CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy
KAZUKI SONE, TETSUYA OGURI, MAKOTO NAKAO, YUSUKE KAGAWA, RYOTA KUROWAKA, HIROMI FURUTA, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, YOSHIHIRO KANEMITSU, HIROTSUGU OHKUBO, MASAYA TAKEMURA, KEN MAENO, YUTAKA ITO, HIDEFUMI SATO, HIDEKI MURAMATSU and AKIO NIIMI

Anticancer Research February 2017, 37 (2) 935-939;

Main menu

User menu

Search

Cytokeratin 19 fragment